Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma
Trial details
- Registry ID
- NCT04006119
- Drugs studied
- Ad-RTS-hIL-12, Cemiplimab-Rwlc, Veledimex
TrialRedline tracks 2 clinical trials sponsored by Alaunos Therapeutics: 2 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive GlioblastomaNCT04006119 | Ad-RTS-hIL-12, Cemiplimab-Rwlc, Veledimex | Terminated | 2021-08-05Actual |
| Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.NCT01703754 | Ad-RTS-hIL-12 and Veledimex, Palifosfamide | Terminated | 2014-08-07Actual |
Names as written in the registry records.